Washington Trust’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-165
| Closed | -$1.46K | – | 547 |
|
|
2025
Q1 | $1.46K | Buy |
165
+9
| +6% | +$80 | ﹤0.01% | 733 |
|
|
2024
Q4 | $2.14K | Sell |
156
-13
| -8% | -$178 | ﹤0.01% | 802 |
|
|
2024
Q3 | $4.63K | Buy |
169
+11
| +7% | +$301 | ﹤0.01% | 746 |
|
|
2024
Q2 | $3.87K | Sell |
158
-3
| -2% | -$73 | ﹤0.01% | 768 |
|
|
2024
Q1 | $3.43K | Sell |
161
-3
| -2% | -$64 | ﹤0.01% | 777 |
|
|
2023
Q4 | $3.14K | Buy |
+164
| New | +$3.14K | ﹤0.01% | 767 |
|